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“They” were always there. Or at least, “they” were there since antiquity; since the time that foraging
for food in the wild invariably meant consuming “them” laced on the food. In the hollow organs
and on the surface, “they” live peacefully, in harmony. “They”: The “Microbiome.” Trillions of
“them”! (Sonnenburg et al., 2004; Bäckhed et al., 2005; Pluznick, 2014; Lanza et al., 2015; McNally
and Brown, 2015; Mermel, 2015; Woolhouse et al., 2015) When the balance gets tipped off, at least
in some organs, clinical signs are manifested. For example, Gardnerella, a common constituent of
vaginal micro-organisms, colonize and smear the epitheliocyte producing the so-called “clue cells,”
and manifest a local secretory phenome, along with odorous volatile substances production, the
“whiff,” so commonly detected during presentations of bacterial vaginosis (BV) in the STI clinic
(Machado and Cerca, 2015). “They” love the lack of oxygen.
The greatest fermentor in the human body is the post-esophageal gut; the anaerobic
environment is capable of producing an environment where gases may be formed, both in the
foregut, through the small intestines, and in the hindgut, with the gradient of bioreactor activity
increasing in that order. We are all so accustomed with the “wind.” Though the precise biological
significance of these luminal gas productions is not known (Azpiroz, 2005), in the surgical ward,
especially after abdominal laparotomy, the history of the passed “wind” is a tale of relief, a sure sign
that the dreaded risk for the development of ileus has passed (Cosyns et al., 2015).
In the foregut, especially in the stomach, casual clinical correlation has been demonstrated
between the presence of Helicobacter pylori and development of gastric ulcers (Marshall and
Warren, 1984). Though the organism has been isolated form the stomach, direct evidence that their
colonization is the first event in development of gastric ulcers has never been provided (Beasley
et al., 2015). Furthermore, recent evidence show that Helicobacter has co-evolved in the human
stomach for several million years and may actually play symbiotic roles (Blaser, 2012; Sitaraman,
2015). In fact, urease producing organisms have been recently demonstrated even in the small
intestines, where the pH is relatively higher (near the alkaline range), and thus there may be special
chemical roles, yet undefined, of urease producing organisms in the alkaline intestinal luminal
environment (Shen et al., 2015).
My reason for this prelude is to generate discussion regarding some recent reports that
have attempted to propose causative link between microbiome populations and their cohort
changes as mechanistic basis for hypertension, continuing the recent trend of linking microbiome
organizations or alterations to chronic diseases. One of this is a recent well-performed study that
endeavors to establish a relation between altered cecal populations of microbes in Dahl salt sensitive
rats as the basis for their hypertension (Mell et al., 2015). I present an alternate viewpoint that
the microbiome changes reported in this manuscript may not necessarily be causative. Previous
studies have proposed the role of gut microbiota and metabolite sensing by G coupled receptors in
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kidney (Pluznick et al., 2013). Oral administration of
Lactobacillus-fermented milk reduce blood pressure in
spontaneously-hypertensive rats (SHR) and humans, and
it has been suggested that this may be mediated by short
peptide sequences from bacterial metabolites (Yamamoto et al.,
1994; Nakamura et al., 1995; Seppo et al., 2003; Sekirov et al.,
2010; Khalesi et al., 2014). Other studies have shown that
the gut microbes metabolize phospholipid to TMAO, and
this may predispose to cardiovascular disease (Wang et al.,
2011). However, TMAO can be well-metabolized (Barrett and
Kwan, 1985) and how this suggested metabolite predispose to
cardiovascular stress is not well established.
In this recent report (Mell et al., 2015), 16S rRNA gene
sequencing obtained from fecal samples of Dahl salt-sensitive
(S) and Dahl salt resistant (R) rats demonstrated that the
phylum Bacteriodetes (family S24-7) and Firmicutes (family
Vellionellaceae) were higher in the S rats compared with the
R rats. Both strains were subjected to the following protocols:
(i) maintained on a high-salt diet (ii) antibiotics treatment for
ablation of microbiota and (iii) transplanted with S or R rat cecal
contents. Blood pressure (BP) monitoring was performed under
the pre-described circumstances.
Surprisingly, antibiotic ablation of gut microbiota of S
rats did not cause significant decrease of blood pressure in
comparison to R rats (Mell et al., 2015). This may support the
inference that colonic microbiota and/or its metabolites may
not play fundamental role in blood pressure elevation in S rats.
Alternatively, we also do not know whether the microbiota
resulted in overgrowth of another intraluminal non-targeted
species. The systolic BP of the R rats remained unchanged when
S rat cecal content was transplanted by trans-gastric gavage.
Reciprocally, when S rats were administered a single bolus of
cecal content from R rats, the systolic BP did not decrease
but showed sustained hypertension during their entire lifespan
(Mell et al., 2015). The temporal profile of the development
of high BP after transplantation of the R contents to S rats
was almost similar to the native (untreated) S strain. These
observations indicate that this may have resulted from the
existing pathology in S rats rather than induced by microbiota
transplant. R rats resist development of high blood pressure
even when fed a high salt (8% NaCl) diet. The authors suggest
that the R cecal transplant induced accelerated hypertension
(Mell et al., 2015). If such is truly the case, then the toxic
components of the R ceca merits to be identified in future
studies. Contrary to the thesis that the authors outline in
their report (Mell et al., 2015), these key observations suggest
that (i) the cecal microbiota and metabolites of S strain do
not contribute to the development of hypertension and (ii)
the R strain cecal microbiota/metabolites potentially restrict
development of hypertension. Rather, the polygenic deregulation
of smooth muscles functions contributing to arteriolar resistance
and other humoral factors that regulate electrolyte homeostasis
and maintenance of normal blood pressure are the potential
contributing factors to development of hypertension in the
salt-sensitive S strain of rats and resistance to development of
hypertension in the salt-resistant R stain of rats (Rapp, 2000;
Zicha et al., 2012).
We shall look forward to validatory studies for the preliminary
observations made in the report. After transplantation of R
contents in S rats, the demise of the rats occurred earlier
than regular S rats (Mell et al., 2015). Necropsy findings,
especially of gross heart morphology, may provide important
data regarding the cause of accelerated mortality (for example,
if development of heart failure due to aggravated hypertension).
The Rcecal to S transplanted group demonstrated increased
plasma acetate and heptanoate but lower levels of fecal
Vellionellaceae (unlike the native S rats; Mell et al., 2015).
Veillonella ferments lactate to acetate via methylmalonyl-CoA
pathway:
Lactate → acetate+ 2propionate+ CO2 +H2O
How acetate remained elevated despite decrease of Veillonella
and the contribution of other organisms, especially the short-
chain fatty acid (butyrate) producing biomass (Duncan et al.,
2004), merits systemic examination in future studies.
Metabonomic studies have provided understanding of gut
metabolism of drugs like simvastatin, one the most commonly
prescribed statins (Aura et al., 2011). Simvastatin is an
inhibitor of the rate-limiting cholesterol synthetic enzyme, 3-
hydroxy-3-methylglutaryl coenzyme A. Simvastatin is degraded
in the gut by hydrolytic cleavage of methylbutanoic acid
from the backbone structure. Metabolism involves sequential
microbial processes of demethylation of dimethylbutanoic acid
and subsequent hydroxylation/dehydroxylation and β-oxidation,
resulting in the production of short chain organic acids like
2-hydroxyisovaleric acid (3-methyl-2-hydroxybutanoic acid),
3-hydroxybutanoic acid and lactic acid (2-hydroxypropanoic
acid), and finally re-cyclization of heptanoic acid to produce
cyclohexanecarboxylic acid. These metabolites may have positive
impact on vascular health. The increased circulating heptanoic
acid in S animals transplanted with R cecal contents (Mell
et al., 2015) may actually be a beneficial metabolite which
may contribute to improved vascular function, rather than
contributing to hypertension. This important aspect merits
clarification in future studies. These aspects are also of
importance in HIV infected patients who are on chronic
ARTs. Some classes of HAART agents like protease inhibitors
and non-nucleoside reverse transcriptase inhibitors (NNRTIs)
predispose to hypercholesterolemia, hypertension and other
dysmetabolic features (da Cunha et al., 2015). Administration
of statins merits careful selection, for example, pravastatin
over other class representatives (in order to prevent statin-
induced myositis and other complications like rhabdomyolysis;
Martínez et al., 2004). How the gut microbes influences such
luminal drug metabolism are important areas of systemic
investigations.
The metabolic role of the luminal microorganisms are
complex, and how they contribute to salt regulation should
be an important area of ongoing studies. Absorption of
sodium chloride from the intestine is complex, and occurs
as a biphasic phenomenon: (a) from the small intestine and
(b) during the entire colonic transit, including in the cecum.
This is further dependent on ileocecal delivery rates, colonic
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transit time and state of luminal electrolyte composition and
viscous state of the luminal mass. In this aspect, studying the
mucin metabolizing organism Akkermansia muciniphila may
also hold important implications (Dao et al., 2015). In the
animal kingdom, not all species have the cecum, for example,
the sloth and the hippopotamus. The sloth is remarkable that
it is a foregut fermentor (Gilmore et al., 2001), like some bird
species like hoatzins and some other animals with complex
stomach compartments belonging to the family Artiodactyla
(suborder Ruminantia, about 150 species; Munn et al., 2008;
Godoy-Vitorino et al., 2012). Other animals that havemechanism
of foregut fermentation include macropods (kangaroos, tree-
kangaroos, wallabies and pademelons) and potoroids (bettongs,
potoroos and rat-kangaroos; Smith, 2009), which demonstrate
a form of rumination called merycism. Folivorous black-tailed
tree rat (Thallomys migricauda) surviving on acacia tree also
shows foregut microorganisms. The foregut microbiota may
play complex roles, including thermoregulation in mousebirds,
providing luminal lysozyme to kill pathogenic bacteria acquired
during foraging or simply toxin regulation, for example
contributing to oxalate metabolism. These organisms also play
major role in nutrient extraction (Ali Shah et al., 2014). It has also
been examined that there is an inverse relationship between the
volume of stomach, especially in foregut fermentors, and volume
of cecum in the hindgut (Langer and Snipes, 1991). These animal
species may provide important control conditions to evaluate the
role of cecal organisms and their changes in hypertension, and
whether foregut fermentation may provide beneficial effects for
blood pressure regulation. A provocative hypothesis could be that
the foregut organisms may play major role in carbon balance
and the production of gases (CO2 + CH4, carbon dioxide and
methane, respectively) may be nature’s way to prevent absorption
of excess carbon units and thus maintain body mass balance. The
critical role of methanogenic bacteria in such context acquires
importance.
There may be complex relationships contributing to the
transit of colonic contents, salt absorption, volume expansion
and contribution to regulation of BP. In my opinion, the most
significant observation in the present study (Mell et al., 2015)
is the change of microbiota composition of the untreated S
rats: the increase in Firmicutes (“tough skin”) and Bacteriodetes.
A previous study reported changes in bacterial super kingdom
level in a mouse obesity model (Ley et al., 2005). Because
obesity potentially may elevate blood pressure, these reverse
changes (increased Firmicutes in comparison to Bacteroidetes in
obesity gut microbiome) from the observations of (Mell et al.,
2015) should be reconciled in future studies. There are other
recent studies that suggest a role of gut microbiome in sleep
apnea induced hypertension (Durgan et al., 2016); however,
diet is an important variable that do not support the role of
the microbiome exclusively to produce the phenotypic effects
(OSA-related hypertension). Detailed metabolic examination
of these two bacterial families may help to understand
the gut luminal environmental contribution to salt balance.
The study by Mell et al. (2015) is a timely stimulus for
active investigation in the field: the role of different diets
(carnivorous, herbivorous, omnivorous and low-salt) and effects
on blood pressure regulation. The findings of the present
study may find future merit in biotechnological innovations.
For example, luminal halophiles that cause morbid infections
like Vibrios may be managed with a probiotic designed on
the cecal composition of R strain of rats (presuming these
organisms have the ability to scavenge sodium). We need
more studies that progress beyond mere cataloging of the
microbiome changes to important chronic medical conditions
like obesity, hypertension and post-infectious irritable bowel
syndrome (IBS). An important control to incorporate during
these studies is the responses of the proposed microbiome using
gnotobiotic and germ-free animals (Shroff and Cebra, 1995;
Cebra et al., 1998). These future investigations shall provide
insights regarding the homeostatic role of the microbiome in
health and mechanistic contribution(s) of their alterations in
disease pathophysiology.
The microorganisms have co-stayed with human host for
millions of years. During disease processes, the Nash equilibrium
between the microbiome and the human host may be reset,
possibly resulting in alterations of specific forms (Cho and
Blaser, 2012). The most pressing issue remains how to ask
the relevant reductionist questions, and how these questions
may be turned to relevant pharmacobiotic products. Similar
repertoire of microbiome changes have been demonstrated in
other models of hypertension. For example, increase in fecal
Firmicutes/Bacteriodetes ratios have been recently demonstrated
in spontaneously hypertensive rats and pharmacologically
induced hypertension (Yang et al., 2015). Interestingly, these
same changes were also demonstrated in stool samples of
a very small series of human hypertensive subjects, and the
trend reversed by anti-hypertensive drugs (Yang et al., 2015).
Gut metabolism of catecholamines may have a biological
impact on blood pressure (Honour, 2015) and during use of
antihypertensives. These aspects should guide future studies.
Deep sequencing of human stool samples of known-cause
and essential human hypertension subjects is a logical and
significant next set of studies. Correlation of clinical conditions
like small intestinal bacterial overgrowth (SIBO) in irritable
bowel syndrome (IBS) and liver diseases, cystic fibrosis, diabetes
mellitus-associated hypertension, ESRD patients, nosocomial
infections, milk intolerance, early-life antibiotic exposure,
antibiotic-associated diarrhea and aging, microbiome/metabolite
changes and possible effects on blood pressure regulation may
be clinically investigated. The translational avenue that merits
logical expansion of these pilot observations are the benefits
from all these research that may be brought upfront to the
clinic. Systemic clinical studies may test the role of probiotics
like Saccharomyces boulardii or Lactobacillus or a fiber-rich diet
in alleviating hypertension. Several cultures around the world
favor fermented milk or organic acid-based drinks, from the
inner plains of Mongolia through rest of the world: in the
form of kefir, dahi, various forms of cheese, yogurt, Evolus,
Calpis milk or kombucha. Basic studies shall help distinguish
whether the reported microbiome changes in hypertension (Mell
et al., 2015; Yang et al., 2015) are simply a bystander effect
and response of microbiome to microenvironmental changes,
or a deeper role as a precedent event to the development
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of hypertension. Preliminary studies have suggested that the
fetus-in-delivery acquires maternal Lactobacillus johnsonii in
preparation for digestion of maternal milk (Aagaard et al.,
2012). Future shall tell us whether old therapies like fecal
enemas (Eiseman et al., 1958) shall come of age as significant
adjunct pharmacotherapy(s) for management of hypertension,
the major cause of all-cause morbidity with advancing age.
These studies (Mell et al., 2015; Yang et al., 2015) are
providing incipient evidence that Paleolithic habits, such as
those followed by Hadza tribes (Schnorr et al., 2014), may
enhance longevity by delaying cardiovascular morbidity. Simple
sharing of Metachnikoff’s advice of the beneficial effects of
milk and yogurt (Metchnikoff, 1910) shall be additive to the
pharmacomanagement of subjects seeking continued care for
essential hypertension and may provide basis for reducing the
challenges of polypharmacy.
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